Can an allocation to smaller companies help investors to capitalise on the ongoing shifts in global supply chains?
Insights
Key considerations for investors as markets await clarity on the Trump administration’s evolving tariff agenda.
European Equities Portfolio Manager Robert Schramm-Fuchs explores the events shaping the future of European markets.
After more than a decade of outperformance, U.S. stocks have come to dominate many equity portfolios.
With U.S. equity leadership broadening beyond mega-cap stocks, active management offers a path to uncover tomorrow’s winners while managing passive investment concentration risks.
New GLP-1 weight-loss drugs have already hit $50 billion in annual sales – and look to have plenty of room to grow.
The sector offers both traditionally defensive holdings and long-term growth potential that now looks attractively valued.
Investors are right to be concerned about policy-driven volatility, but at the same time should recognize the importance of staying invested during periods of uncertainty.
A resilient U.S. economy has helped push up valuations of certain stocks, making it all the more important to focus on fundamentals.
DeepSeek's open-source AI model has shaken the market – what does it mean for European companies involved in the race for AI dominance?
Why we believe the recent slide in healthcare stocks presents a potential buying opportunity.